Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab
2021 · The Breast · 9 citations
https://doi.org/10.1016/j.breast.2021.03.004
A
Arianna Marinello
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
299
Citations
9
h-index
7
i10-index
Arianna Marinello is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics & Lung Cancer Research Studies. The author has an h-index of 9, co-authored 51 publications.
ORCID: 0000-0003-3966-1984Papers by this author
worksProspective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non–Small-Cell Lung Cancer
2021 · Clinical Lung Cancer · 7 citations
https://doi.org/10.1016/j.cllc.2020.12.007
Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
2024 · JTO Clinical and Research Reports · 1 citations
https://doi.org/10.1016/j.jtocrr.2024.100773
Immune-checkpoint targeting drug conjugates: a novel class of promising therapeutic agents for cancer treatment
2025 · npj Precision Oncology · 1 citations
https://doi.org/10.1038/s41698-025-01011-7
113 (PB101): Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer
2024 · European Journal of Cancer · 0 citations
https://doi.org/10.1016/j.ejca.2024.114636
4MO Role of ctDNA tumor fraction to select immunotherapy based regimens in advanced non-small cell lung cancer
2024 · Immuno-Oncology Technology · 0 citations
https://doi.org/10.1016/j.iotech.2024.100888
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat